Rhythm Pharmaceuticals (RYTM) Receivables (2021 - 2026)
Rhythm Pharmaceuticals (RYTM) reported Receivables of $40.41 million for Q2 2026, up 54.7% from $26.12 million a year earlier and up 18.2% from the prior quarter.
Powered by 
Analysis
Rhythm Pharmaceuticals (RYTM) Receivables (2021 - 2026) Analysis & Trends
At the end of FY2025, Rhythm Pharmaceuticals posted Receivables of $26.08 million, up 40.9% from FY2024.
- Receivables has increased for four consecutive years, with a four-year compound annual growth rate of 124.6% (FY2021 to FY2025).
- By year, Receivables came in at $18.51 million in FY2024 (+24.5%), $14.87 million in FY2023 (+138.9%), $6.22 million in FY2022 (+507.2%) and $1.03 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Receivables in data going back to Q4 2021.
- Year over year, Receivables has now increased in each of the last 15 quarters, with growth averaging 48.2% over the last eight quarters.
- The year-over-year growth in Receivables has ranged between 21.3% (Q1 2025) and 841.6% (Q1 2023) over the last five years.
- Per Business Quant data, the three quarters before Q2 2026 came in at $34.19 million (Q1 2026), $26.08 million (Q4 2025) and $33.03 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Rhythm Pharmaceuticals | 6.78 Bn | 5.65 Bn | 62.32 Mn | 40.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 40.41 Mn |
| Mar 31, 2026 | 34.19 Mn |
| Dec 31, 2025 | 26.08 Mn |
| Sep 30, 2025 | 33.03 Mn |
| Jun 30, 2025 | 26.12 Mn |
| Mar 31, 2025 | 17.83 Mn |
| Dec 31, 2024 | 18.51 Mn |
| Sep 30, 2024 | 19.31 Mn |
| Jun 30, 2024 | 17.60 Mn |
| Mar 31, 2024 | 14.70 Mn |
| Dec 31, 2023 | 14.87 Mn |
| Sep 30, 2023 | 14.54 Mn |
| Jun 30, 2023 | 13.83 Mn |
| Mar 31, 2023 | 8.12 Mn |
| Dec 31, 2022 | 6.22 Mn |
| Sep 30, 2022 | 3.33 Mn |
| Jun 30, 2022 | 1.71 Mn |
| Mar 31, 2022 | 862,000.00 |
| Dec 31, 2021 | 1.03 Mn |
API Access
Rhythm Pharmaceuticals Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=RYTM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "RYTM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=RYTM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();